Skip to main content

Security report for biovendor.group

BioVendor Group · Healthcare · Czech Republic

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 2 other checks.

Security score

63/100

Risk levelMedium

0–100, higher is better. How it is calculated

BioVendor Group is a medium-sized healthcare and technology company specializing in the development, production, and distribution of innovative diagnostic products and technologies for laboratory diagnostics. The company positions itself as a technological leader with multiple brands and a strong focus on research and innovation. Their target audience includes physicians, patients, diagnostic laboratories, and the scientific community worldwide. The website reflects a professional and consistent brand image with clear navigation and relevant content about their key projects and services. Technically, the website employs modern JavaScript libraries such as jQuery and Slick Carousel, uses Google Tag Manager for analytics, and is optimized for mobile devices with good SEO practices. The site is served over HTTPS with no visible security vulnerabilities in the content. Privacy and cookie policies are implemented with consent mechanisms, indicating a good level of privacy compliance. However, no explicit security policies or incident response contacts are published. From a security perspective, the website demonstrates good practices such as HTTPS enforcement and cookie consent but lacks published security policies and incident response information. The WHOIS data is malformed and incomplete, which reduces trustworthiness from a domain registration perspective. Despite this, the professional website content and branding mitigate some concerns. No adult or questionable content is present, making the site safe for general audiences. Overall, the website is well-designed, functional, and professional with moderate technical maturity and good privacy compliance. The main risk lies in the incomplete WHOIS data, which should be monitored. Strategic recommendations include publishing security and incident response policies, improving accessibility, and enhancing security headers to strengthen the security posture and trustworthiness.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
  4. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • High

      High-Risk Service Exposed: FTP

      Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

      What to do: Consider restricting access to FTP or implementing strong authentication

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

Need hands-on remediation? Email guard@offseq.com

Keep watching biovendor.group

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
65
Email security
85
DNS health
80
Network security
20
GDPR outside view
53
Average
63

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention biovendor.group, from OffSeq Breach.

No leaked records found

Breach holds no records for biovendor.group right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

BioVendor Group operates in the healthcare diagnostics sector with a diversified portfolio of brands and innovative projects such as CLIA, Microblot-Array, Next Generation Sequencing, miRNA, and LAMP. Their business model focuses on research-driven product development and global distribution. The company targets diagnostic laboratories, healthcare providers, and researchers. The presence in over 115 countries and a workforce of over 500 employees indicate a medium-sized enterprise with significant market reach. The company leverages partnerships and subsidiaries to cover various diagnostic fields, enhancing its competitive advantage. The website content and event participation suggest active engagement in industry education and innovation. No direct revenue or financial data is available, but the breadth of products and global presence imply stable growth and market positioning.

Security posture

The website enforces HTTPS and uses Google Tag Manager for analytics with privacy consent mechanisms, reflecting a baseline security posture. No security headers were detected in the provided data, and no explicit security or incident response policies are published, indicating room for improvement. The absence of exposed sensitive data and secure form handling are positive indicators. The malformed WHOIS data is a concern for domain trust but does not directly impact website security. Overall, the security maturity is moderate, with recommendations to implement security headers, publish security policies, and provide incident response contacts to enhance transparency and readiness.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and compliance.
  2. Add incident response contact information or abuse reporting channels on the website.
  3. Implement and configure security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  4. Improve website accessibility features to meet WCAG standards for broader user inclusivity.
  5. Monitor and resolve WHOIS data issues to improve domain registration transparency and trust.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
BioVendor Group
Description
We develop, produce and distribute products and technologies for laboratory diagnostics. Our products are redefining the standards of cutting-edge diagnostics.
Key services
Diagnostic product development, Laboratory diagnostics solutions, Immunodiagnostics, Molecular diagnostics, Research and innovation
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Slick Carousel, OpenTypeKit fonts, Google Tag Manager
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Consent management for cookies
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Tag Manager
Tracking level
minimal
Privacy practices
good

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation.
  2. No direct contact emails or phone numbers found; only contact form available.
  3. No explicit security or incident response policies published.
  4. WHOIS data is incomplete and does not provide registrant details.
  5. Website uses modern JavaScript libraries and Google Tag Manager for analytics.
  6. Privacy and cookie policies are present with consent mechanisms.
  7. No signs of adult or questionable content.
  8. Multiple brands and subsidiaries are clearly presented.
  9. Social media presence on LinkedIn and YouTube.
Technical notes

Notes

The website uses a modern front-end stack with jQuery and Slick Carousel for UI components and Google Tag Manager for analytics. Fonts are loaded via Adobe Typekit. The site is mobile optimized with responsive images and layout. No CMS or hosting provider information is evident from the HTML. Performance is moderate with asynchronous loading of analytics scripts. SEO is supported by proper meta tags and Open Graph data. Accessibility is basic but could be improved. No critical technical debt or vulnerabilities were detected in the HTML content. The site uses standard HTML5 and CSS with no deprecated elements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with biovendor.group. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biovendor.group.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.